INTRODUCTION
Escherichia coli trains are a very diverse species of bacteria found naturally in the intestinal tract of all humans and many other animal species. A subset of E. coli is capable of causing enteric/diarrheal diseases and a different cluster causes extra-intestinal infections, including urinary tract infection (UTI) (1) . Uropathogenic E. coli (UPEC), a gram negative bacillus, is the main etiologic agent and predominant microorganism causing UTIs (in 50-80z) (2) (3) (4) . UTI is the most common bacterial infectious disease encountered in clinical practice, accounting for considerable morbidity rates and high medical costs (4) . UTIs are one of the most prevalent and significant community-acquired and nosocomial infections, with 150 million cases of this extraintestinal infection occurring annually worldwide (5, 6) . Moreover, UTI has become a global public health problem especially in hospitals owing to its high mortality rate in humans, and complications including hypertension, chronic renal failures, chronic pyelonephritis, and dramatically increased drug resistance (7, 8) . The severity of UTI produced by E. coli is due to the expression of a wide spectrum of antimicrobial resistance genes. The level of resistance to different antibiotics, and even that of spontaneous resistance to several antibiotics in E. coli strains are growing. This increased rate of drug resistance has induced the emergence of multiple drug resistance (MDR) in UPEC strains. MDR was described as the non-susceptibility to at least one agent in 3 or more antimicrobial classes (9) . Resistant E. coli strains are emerging globally as a threat to the favorable outcome of common infections in community and hospital settings. These conditions are increasing particularly in developing or third-world countries that frequently use antibiotic agents in both animals and humans, where people consume antibiotics without the supervision or prescription of a physician (10, 11) . Inappropriate antibacterial treatment and misuse of antibiotics have contributed to the emergence of antibacterial-resistant bacteria (12) . The rate of MDR among UTI isolates changes across different geographic regions. For example, the prevalence of MDR-UPEC was reported to be 92z in India (13) , whereas the prevalences in the United States and Slovenia were 7.1z and 42z, respectively (14, 15) . Although, several studies have presented local information about the rate of MDR-UPEC in different cities of Iran, the average rate of MDR UPEC in Iranian hospitals is still unknown (16) .
In the present study, we aimed to systematically the review the published data about the prevalence rate of MDR-UPEC from different parts of Iran and to establish the overall relative frequency (RF) for Iran by using meta-analysis.
MATERIALS AND METHODS
Search strategy: PubMed, ISI Web of Science, Scopus, and Google Scholar were searched (up to March 2015) by using the following keywords:``Escherichia coli'',``multi drug resistant'',``MDR'',``urinary tract infections'',``UTI'',``uropathogenic'', and``Iran''. In addition to articles published in English, 2 Persian scientific search engines, Iranian Scientific Information Database <www.sid.ir> (SID), and IranMedex <www. iranmedex.ir> were also searched for relevant articles. No limitation was used in the search of the databases. The references lists of all related studies were also reviewed for any other related publications. The search was restricted to original articles/abstracts published in English and in Persian that reported the prevalence of MDR-UPEC measured by using disk diffusion method in Iran. All these steps were done by 4 authors (MS, MM, SH, and RR), and any disagreements concerning article selection were resolved through a discussion. The corresponding author (MS) was available to resolve any disagreement.
Inclusion criteria: Among the English and Persian articles/abstracts found with the above strategies, those with the following features were included in the study: (i) UPEC samples were collected from Iranian hospitals because this review study is limited to Iran, and its purpose was to measure the prevalence of MDR-UPEC strains in this country alone; (ii) the clinical specimens were taken from patients. If there were specimens from hospital personnel, the personal results were not included in the analysis because those samples were collected from patients with repetitive sampling and therefore not valid. Therefore, all of the studies that have been included in this survey have been conducted on clinical samples from patients; (iii) the disk diffusion method (Kirby-Bauer) was used to find the MDR-UPEC strains because this method is the standard phenotypic assay used in most studies on antibiotic resistance patterns and in studies demonstrating the MDR of bacterial strains.
Exclusion criteria: Articles were excluded from the review if (i) the samples were partially/totally selected from UPEC collections (i.e., UPEC samples collected and stored previously); (ii) other phenotypic methods instead of Kirby-Bauer were used for the identification of MDR-UPEC strains; (iii) the origin of the samples was unclear, (i.e., the reviewer(s) could not determine which region or population [for example, inpatients, personnel, or outpatients] the specimens were gathered from); and (iv) the review articles, congress abstracts, or studies were reported in languages other than English or Persian, as well as if the article/abstracts were from a meta-analysis or systematic reviews, or a duplicate publication of the same study (or a study published both in English and in Persian). Concerning the duplicate publications, the study with a bigger sample size or with more detailed results were chosen for our systematic review.
Data collection: For all studies, the following data were extracted: last name of the first author, publication date, sample size, study setting, study enrollment time, number of participants with MDR-UPEC, the RF of MDR-UPEC strains, drug resistance status (MDR), and research location. Two authors independently extracted the data from all of the included studies. Inconsistencies between the reviewers were discussed to reach consensus.
Statistical analysis: The total number of participants and the number of participants with MDR-UPEC isolates were used to estimate the RF which was then converted to log RF and its standard error (SE) to be included in the meta-analysis (17) . Summary effects were derived by using a random effects model, which takes between-study variation into account (18) . Between study heterogeneities were assessed by using a Cochran's Q-test and the I-square (I 2 ) test (17) . A sensitivity analysis was used to examine the extent to which the overall summary effect might depend on a particular study or a group of publications. Publication bias was checked by using Begg's funnel plots (19) and asymmetry tests including Egger's regression test and Begg's adjusted rank correlation test (18) . All statistical analyses were conducted by using STATA version 11.2 (STATA Corp, College Station, TX, USA). P values ＜0.05 were considered statistically significant.
RESULTS
A total of 7,431 articles were retrieved through the database search. The summary of the literature search and study selection is shown in Fig. 1 . In a secondary screening process, 3,277 of the publications were excluded based on an evaluation of the titles and abstracts, and 279 articles were retained for a detailed full-text evaluation. After the full-text evaluation, 15 articles (abstract with full-text articles) describing the prevalence of MDR-UPEC in Iran were selected for analysis and are presented in Table 1 . In the studies that we investigated, the samples included infectious urine specimens taken from outpatients and hospitalized patients, both man and woman and across different ages. Most of the studies were conducted in central and west Iran, followed by south Iran. Fig. 2 shows the distribution of MDR-UPEC across different regions of Iran.
The status of MDR-UPEC strains in Iran is shown in Table 2 . From the random-effects model, the prevalence of MDR-UPEC strains was found to be 49.4z (95z confidence interval [CI]: 48.0-50.7z). However, an evident heterogeneity of MDR-UPEC RF was observed among studies (Cochran's Q test, P ＜ 0.001, I 2 ＝ 98z). Fig. 3 shows the forest plot of the metaanalysis of MDR-UPEC. As shown in Fig. 4 , although a slight asymmetry was seen in Begg's funnel plot, this was not confirmed by statistical asymmetry tests (P ＝ 0.447 for Begg's rank correlation analysis; P ＝ 0.625 for Egger's weighted regression analysis). 
DISCUSSION
The high prevalence of UPEC infections across different ages and in different parts of the country, especially in hospitals, as well as the increasing antibiotic resistance of this pathogen, led us to undertake this meta-analysis and systematic review. The present study was designed to estimate the prevalence and distribution of MDR-UPEC in the Iranian population according to available data from articles collected from different parts of the country by Iranian researchers. (57) .
Iran clearly has a lower prevalence of MDR-UPEC than other Asian countries (India, Pakistan, Nepal, Saudi Arabia, and Bangladesh) and also has a lower prevalence than African countries (Egypt, Sudan, Ethiopia, and Nigeria). In contrast, Iran has a higher prevalence of MDR-UPEC than European countries (the Netherlands, Germany, and Belgium) and the United States. Taking these results together, although the presence of MDR strains in Iranian UPEC isolates is less than those in Asian and African isolates, the rate is relatively high compared with some other countries. This finding indicates that the prevalence and distribution of MDR isolates in developing countries is much greater than those in developed countries, and that physicians and health-care centers may face difficulties in treating half of UTI cases due to UPEC infections in Iran.
This meta-analysis has several limitations that should be considered. First, non-English literature could not be reviewed because of the language barrier. Second, this study cannot fully represent Iran because there were no data on MDR-UPEC from many parts of the country (e.g., east, northeast, and southeast Iran). Third, owing to limited access to in-press articles and theses, some studies might have been missed, which was also suggested by the statistical analysis. Fourth, heterogeneity exists among the included studies. Although the random-effects model allows for the presence of heterogeneity, there may still be some controversy about combining study estimates in its presence. Finally, as with any systematic review, limitations associated with potential publication bias should be considered. In comparison with similar studies, the RF of MDR-UPEC in Iran is moderately high; thus, measures should be taken to keep the emergence and transmission of these strains to a minimum. Careful monitoring of MDR strains and early detection of these isolates by using phenotypic and genotypic laboratory methods are recommended for the prevention and control of MDR-UPEC in Iran. Guidelines for physicians and personnel are needed to prevent the spread of these strains in hospitals. stant encouragement and support of research for this study. We are also thankful to all the faculty members of``Microbiology'',``Virology'', and``Epidemiology and Biostatistics'' Departments for technical assistance in research.
